Xiaotun Zhang

3.9k total citations
37 papers, 1.7k citations indexed

About

Xiaotun Zhang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xiaotun Zhang has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Xiaotun Zhang's work include Prostate Cancer Treatment and Research (26 papers), Bone health and treatments (8 papers) and Cancer, Lipids, and Metabolism (6 papers). Xiaotun Zhang is often cited by papers focused on Prostate Cancer Treatment and Research (26 papers), Bone health and treatments (8 papers) and Cancer, Lipids, and Metabolism (6 papers). Xiaotun Zhang collaborates with scholars based in United States, Macao and South Africa. Xiaotun Zhang's co-authors include Colm Morrissey, Peter S. Nelson, Robert L. Vessella, Ilsa M. Coleman, Lawrence D. True, Eva Corey, Celestia S. Higano, Stephen R. Plymate, Shihua Sun and Funda Vakar‐Lopez and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xiaotun Zhang

37 papers receiving 1.7k citations

Peers

Xiaotun Zhang
Anh Hoang United States
Adam G. Sowalsky United States
Lisha G. Brown United States
Theresa Y. MacDonald United States
Ryon P. Graf United States
Debyani Chakravarty United States
Rohan Bareja United States
Gary R. MacVicar United States
Anh Hoang United States
Xiaotun Zhang
Citations per year, relative to Xiaotun Zhang Xiaotun Zhang (= 1×) peers Anh Hoang

Countries citing papers authored by Xiaotun Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaotun Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotun Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotun Zhang more than expected).

Fields of papers citing papers by Xiaotun Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotun Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotun Zhang. The network helps show where Xiaotun Zhang may publish in the future.

Co-authorship network of co-authors of Xiaotun Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotun Zhang. A scholar is included among the top collaborators of Xiaotun Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotun Zhang. Xiaotun Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Shang, Xiangqi Meng, Ruihua Liu, et al.. (2021). Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases. Cancer Letters. 525. 170–178. 11 indexed citations
2.
Zhang, Ailin, Daniella Bianchi‐Frias, Eunpi Cho, et al.. (2019). Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy. Prostate Cancer and Prostatic Diseases. 22(4). 560–568. 15 indexed citations
3.
Mostaghel, Elahe A., Ailin Zhang, Susana Hernández, et al.. (2018). Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(1). 426–439. 49 indexed citations
4.
Zhang, Xiaotun, et al.. (2018). Cervical Lymph Node Fine-Needle Aspiration and Needle-Wash Thyroglobulin Reflex Test for Papillary Thyroid Carcinoma. Endocrine Pathology. 29(4). 346–350. 10 indexed citations
5.
Zhang, Xiaotun, Andrea Jones, Sarah M. Jenkins, & Yajue Huang. (2018). Ki67 Proliferative Index in Carcinoid Tumors Involving Ovary. Endocrine Pathology. 29(1). 43–48. 12 indexed citations
6.
Nghiem, Belinda, Xiaotun Zhang, Hung‐Ming Lam, et al.. (2016). Mismatch repair enzyme expression in primary and castrate resistant prostate cancer. Asian journal of urology. 3(4). 223–228. 14 indexed citations
7.
Zhang, Xiaotun, Ilsa M. Coleman, Lisha G. Brown, et al.. (2015). SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 21(20). 4698–4708. 129 indexed citations
8.
Zhang, Xiaotun, Ilsa M. Coleman, Nolan G. Ericson, et al.. (2015). Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases. Clinical & Experimental Metastasis. 33(3). 239–248. 27 indexed citations
9.
Pritchard, Colin C., Colm Morrissey, Akash Kumar, et al.. (2014). Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer. Nature Communications. 5(1). 4988–4988. 199 indexed citations
10.
Mostaghel, Elahe A., Andrew Morgan, Xiaotun Zhang, et al.. (2014). Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis. PLoS ONE. 9(10). e111545–e111545. 5 indexed citations
11.
Bluemn, Eric G., Brigham H. Mecham, Ryan R. Gordon, et al.. (2013). PPP2R2C Loss Promotes Castration-Resistance and Is Associated with Increased Prostate Cancer-Specific Mortality. Molecular Cancer Research. 11(6). 568–578. 36 indexed citations
12.
Liu, Gang, Cynthia C.T. Sprenger, Shihua Sun, et al.. (2013). AR Variant ARv567es Induces Carcinogenesis in a Novel Transgenic Mouse Model of Prostate Cancer. Neoplasia. 15(9). 1009–IN3. 56 indexed citations
13.
Larson, Sandy, Xiaotun Zhang, Lisha G. Brown, et al.. (2013). Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment. Clinical & Experimental Metastasis. 31(2). 247–256. 18 indexed citations
14.
Sottnik, Joseph L., Stephanie Daignault‐Newton, Xiaotun Zhang, et al.. (2012). Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis. Clinical & Experimental Metastasis. 30(5). 569–578. 79 indexed citations
15.
Zhang, Xiaotun, Wenbin Wang, Gregory J. Mize, et al.. (2012). Protease-activated receptor 2 signaling upregulates angiogenic growth factors in renal cell carcinoma. Experimental and Molecular Pathology. 94(1). 91–97. 12 indexed citations
16.
Zhang, Xiaotun, Colm Morrissey, Shihua Sun, et al.. (2011). Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases. PLoS ONE. 6(11). e27970–e27970. 200 indexed citations
17.
Sharma, Ankur, Wen-Shuz Yeow, Adam Ertel, et al.. (2010). The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. Journal of Clinical Investigation. 120(12). 4478–4492. 251 indexed citations
18.
Zhang, Xiaotun, Wenbin Wang, Lawrence D. True, Robert L. Vessella, & Thomas K. Τakayama. (2009). Protease‐activated receptor‐1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis. The Prostate. 69(7). 727–736. 23 indexed citations
19.
Wang, Wenbin, Gregory J. Mize, Xiaotun Zhang, & Thomas K. Τakayama. (2009). Kallikrein‐related peptidase‐4 initiates tumor–stroma interactions in prostate cancer through protease‐activated receptor‐1. International Journal of Cancer. 126(3). 599–610. 35 indexed citations
20.
Wang, Wenbin, Xiaotun Zhang, Gregory J. Mize, & Thomas K. Τakayama. (2008). Protease‐activated receptor‐1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia. The Prostate. 68(10). 1064–1075. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026